On November 3, 2023, Mustang Bio, Inc. closed the transaction. The transaction included participation from a single investor. In connection with the offering, the placement agent received is $308,000.08 and warrants to purchase up to 155,294 shares of common stock exercisable at $2.125 per share.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.142 USD | -4.38% | -20.49% | -89.45% |
May. 15 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.45% | 4.18M | |
+18.14% | 125B | |
+13.06% | 108B | |
-7.03% | 24.21B | |
+1.54% | 22.78B | |
-10.97% | 17.96B | |
-41.74% | 16.43B | |
-13.25% | 16.37B | |
+0.75% | 13.58B | |
+26.92% | 11.66B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. announced that it has received $4.742942 million in funding